Next to the direct effect of MCs and mediators on tumor growth, it is also possible that MCs modulate anti-tumor immunity by recruiting and activating other immune effector cells like dendritic cells, NK cells, CD8+ cytotoxic T lymphocytes, and CD4+ Th1 cells at tumor sites [11]. The gene discussed is CD8A; the disease is neoplasm.